# Targeting Platelet-Leukocyte Aggregates in Pneumonia With Ticagrelor

> **NCT01883869** · PHASE1 · COMPLETED · sponsor: **University of Kentucky** · enrollment: 60 (actual)

## Conditions studied

- Pneumonia
- Community Acquired Pneumonia
- Hospital Acquired Pneumonia
- Acute Lung Injury

## Interventions

- **DRUG:** ticagrelor
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01883869
- **Lead sponsor:** University of Kentucky
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2016-06
- **Final completion:** 2016-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01883869

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01883869, "Targeting Platelet-Leukocyte Aggregates in Pneumonia With Ticagrelor". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01883869. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*